文献速递脑血管病认知障碍与痴呆

高血清脑源性神经营养因子水平与卒中后认知障碍风险降低相关

High-Serum Brain-Derived Neurotrophic Factor Levels Are Associated With Decreased Risk of Poststroke Cognitive Impairment.
PubMed 文献 · Stroke · 2024-01-18

本研究为CATIS试验预计划辅助研究,纳入660例高血压缺血性卒中患者,最终分析593例,检测基线血清BDNF水平,随访3个月用MMSE和MoCA评估认知功能。调整混杂因素后,BDNF最高三分位组较最低三分位组PSCI的OR为0.60(95%CI 0.39-0.94;P=0.024),呈线性关联,提示血清BDNF可能是PSCI的潜在预测生物标志物。

要点

  • 高血压缺血性卒中患者基线血清BDNF最高三分位组3个月PSCI风险较低三分位组降低,OR=0.60(95%CI 0.39-0.94;P=0.024)。
  • 血清BDNF与3个月PSCI呈线性关联(线性P=0.010)。
  • 将血清BDNF加入常规预后因素可轻微改善PSCI风险重分类(NRI=27.46%,P=0.001;IDI=1.02%,P=0.015)。

核心结论

  • 升高的血清BDNF水平与3个月PSCI风险降低相关,提示血清BDNF可能是高血压缺血性卒中患者PSCI的潜在预测生物标志物。

研究设计与样本

  • 基于CATIS试验的预计划辅助研究,多中心设计。
  • 共纳入660例高血压缺血性卒中患者,最终593例纳入分析(平均年龄59.90±10.44岁;男性410例,女性183例)。

主要发现

  • 根据MMSE评分定义PSCI,调整年龄、性别、教育程度、基线NIHSS评分、APOE ɛ4携带状态及其他潜在混杂因素后,BDNF最高三分位组较最低三分位组PSCI的OR为0.60(95%CI 0.39-0.94;P=0.024)。
  • 多变量调整样条回归模型显示血清BDNF水平与3个月PSCI呈线性关联(线性P=0.010)。
  • 将血清BDNF加入常规预后因素可轻微改善PSCI风险重分类(NRI=27.46%,P=0.001;IDI=1.02%,P=0.015)。
  • 当PSCI由MoCA评分定义时,观察到相似的显著结果。

关键数值与推荐

  • PSCI定义为MMSE评分<27分或MoCA评分<25分。
  • 血清BDNF最高三分位组较最低三分位组PSCI的OR=0.60(95%CI 0.39-0.94;P=0.024)。
  • 线性关联检验P=0.010。
  • NRI=27.46%,P=0.001;IDI=1.02%,P=0.015。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: BDNF (brain-derived neurotrophic factor) is widely implicated in the pathophysiological process of stroke, but the effect of BDNF on poststroke cognitive impairment (PSCI) remains unclear. We aimed to investigate the association between baseline serum BDNF and the risk of PSCI at 3 months in a multicenter study based on a preplanned ancillary study of the CATIS trial (China Antihypertensive Trial in Acute Ischemic Stroke). METHODS: We examined serum BDNF levels at baseline and used the Mini-Mental State Examination and Montreal Cognitive Assessment to evaluate cognitive function at 3-month follow-up after ischemic stroke. PSCI was defined as Mini-Mental State Examination score <27 or Montreal Cognitive Assessment score <25. Logistic regression analyses were performed to evaluate the association between serum BDNF and the risk of 3-month PSCI. RESULTS: In this ancillary study, a total of 660 patients with ischemic stroke with hypertension were included, and 593 patients (mean age, 59.90±10.44 years; 410 males and 183 females) were finally included in this analysis. According to mini-mental state examination score, after adjustment for age, sex, education, baseline National Institutes of Health Stroke Scale score, APOE ɛ4 carriers, and other potential confounders, the odds ratio of PSCI for the highest tertile of BDNF was 0.60 ([95% CI, 0.39-0.94]; P=0.024) compared with the lowest tertile. Multiple-adjusted spline regression model showed a linear association of serum BDNF levels with PSCI at 3 months (P value for linearity=0.010). Adding serum BDNF to conventional prognostic factors slightly improved the risk reclassification of PSCI (net reclassification improvement: 27.46%, P=0.001; integrated discrimination index: 1.02%, P=0.015). Similar significant findings were observed when PSCI was defined by the Montreal Cognitive Assessment score. CONCLUSIONS: Elevated serum BDNF levels were associated with a decreased risk of PSCI at 3 months, suggesting that serum BDNF might be a potential predictive biomarker for PSCI among patients with ischemic stroke with hypertension.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Chang X, You J, Yang P, et al. High-Serum Brain-Derived Neurotrophic Factor Levels Are Associated With Decreased Risk of Poststroke Cognitive Impairment. Stroke. 2024. PMID: 38235585. doi:10.1161/STROKEAHA.123.044698

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。